George Washington-Medical Faculty Associates

Washington D.C., District of Columbia 20052

3 studies enrolling now · 22 studies all time

What they study most

AIDS, Amyotrophic Lateral Sclerosis, Atopic Dermatitis, Breast - Female, Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, COVID-19, Carcinoma, Breast, Carcinoma, Non-Small-Cell Lung, Chemotherapy Induced Alopecia

Studies at this site

• A Study to Learn About mRNA Vaccines Against Influenza in Adults — Recruiting now
• Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) — Recruiting now
• The DC Cohort Longitudinal HIV Status Neutral Study — Recruiting now
• Tucatinib+Trastuzumab+Eribulin in HER2+ MBC — Running, not enrolling
• A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy — Completed
• Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
• CARE (Chemotherapy Alopecia REduction) — Running, not enrolling
• PositiveLinks: mHealth for DC Cohort — Completed
• A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) — Completed
• Respiratory Virus Hospitalization Study (FLU 003 Plus) — Completed
• A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) — Stopped early
• Strategic Timing of Antiretroviral Treatment — Completed
• Renasight Clinical Application, Review and Evaluation (RenaCARE) Study — Status unconfirmed
• Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) — Stopped early
• Topical Collagen Powder for Healing of Acute Full-thickness Wounds — Completed
• Predictive Assay for Decision Making in Adjuvant Therapy — Stopped early
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• CXA-10 Study in Subjects With Pulmonary Arterial Hypertension — Stopped early
• PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) — Stopped early
• A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures — Completed
• Respiratory Virus Outpatient Study (FLU 002 Plus) — Completed
• Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM) — Completed